Suppr超能文献

采用基于高通量微阵列的原纤维蛋白-1 基因突变分析方法评估马凡综合征日本患者。

Evaluating Japanese patients with the Marfan syndrome using high-throughput microarray-based mutational analysis of fibrillin-1 gene.

机构信息

Department of Cardiovascular Medicine, Graduate School of Medicine, University of Tokyo, Japan.

出版信息

Am J Cardiol. 2011 Dec 15;108(12):1801-7. doi: 10.1016/j.amjcard.2011.07.053. Epub 2011 Sep 10.

Abstract

Marfan syndrome (MS) is an inherited connective tissue disorder, and detailed evaluations of multiple organ systems are required for its diagnosis. Genetic testing of the disease-causing fibrillin-1 gene (FBN1) is also important in this diagnostic scheme. The aim of this study was to define the clinical characteristics of Japanese patients with MS and enable the efficient and accurate diagnosis of MS with mutational analysis using a high-throughput microarray-based resequencing system. Fifty-three Japanese probands were recruited, and their clinical characteristics were evaluated using the Ghent criteria. For mutational analysis, an oligonucleotide microarray was designed to interrogate FBN1, and the entire exon and exon-intron boundaries of FBN1 were sequenced. Clinical evaluation revealed more pulmonary phenotypes and fewer skeletal phenotypes in Japanese patients with MS compared to Caucasians. The microarray-based resequencing system detected 35 kinds of mutations, including 23 new mutations. The mutation detection rate for patients who fulfilled the Ghent criteria reached 71%. Of note, splicing mutations accounted for 19% of all mutations, which is more than previously reported. In conclusion, this comprehensive approach successfully detected clinical phenotypes of Japanese patients with MS and demonstrated the usefulness and feasibility of this microarray-based high-throughput resequencing system for mutational analysis of MS.

摘要

马凡综合征(MS)是一种遗传性结缔组织疾病,需要对多个器官系统进行详细评估才能确诊。对致病纤维连接素 1 基因(FBN1)进行基因检测也是该诊断方案中的重要一环。本研究旨在定义日本 MS 患者的临床特征,并通过高通量基于微阵列的重测序系统进行突变分析,实现 MS 的高效、准确诊断。共招募了 53 名日本先证者,并使用根特标准评估其临床特征。进行突变分析时,设计了一个寡核苷酸微阵列来检测 FBN1,并对 FBN1 的整个外显子和外显子-内含子边界进行测序。临床评估显示,与高加索人相比,日本 MS 患者的肺部表型更多,骨骼表型更少。基于微阵列的重测序系统检测到 35 种突变,包括 23 种新突变。符合根特标准的患者的突变检测率达到 71%。值得注意的是,剪接突变占所有突变的 19%,高于之前的报道。总之,这种综合方法成功地检测到了日本 MS 患者的临床表型,并证明了这种基于微阵列的高通量重测序系统对 MS 突变分析的有效性和可行性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验